Back to COGT
Patient Square Capital LP → COGT
Patient Square Capital LP COGT Position History
Cogent Biosciences, Inc. • Healthcare
Quarters held
4
Latest value
$11.6M
Q3 2026
Peak value
$22.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $11.3M |
| Q1 2026 | $22.9M |
| Q2 2026 | $16.4M |
| Q3 2026 | $11.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $11.6M | 361.9K | — | — |
| Q2 2026 | $16.4M | 425.0K | — | — |
| Q1 2026 | $22.9M | 596.0K | — | — |
| Q4 2025 | $11.3M | 317.4K | — | — |
Other funds holding COGT
$868.7M
$808M
$756M
$706.8M